{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:12:00Z","timestamp":1753877520272,"version":"3.41.2"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tuberculosis infection (TBI) and chronic hepatitis B virus (HBV) infection disproportionately affect non\u2013US-born persons. Early identification and treatment are critical to reduce transmission, morbidity, and mortality, but little is known about screening in the United States.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a cross-sectional study in a large integrated California health system in September 2022 assessing TBI and HBV screening among persons aged \u226518 years who were born in countries with high TB burden (TB disease incidence rates \u226520\/100 000 population) and\/or HBV burden (hepatitis B surface antigen seroprevalence &amp;gt;2%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 510 361 non\u2013US-born persons born in countries with high TB burden, 322 027 (63.1%) were born in countries with high HBV burden and 188 334 (36.9%) in countries with only high TB burden. Among persons born in countries with high TB and HBV burden, 29.6% were screened for TBI, 64.5% for HBV, and 23.4% for TBI and HBV; 9.9% had TBI and 3.1% had HBV infection. Among persons born in countries with high TB burden only, 27.9% were screened for TBI and 7.5% had TBI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among non\u2013US-born persons from countries with high TB and HBV burden, we found low screening rates and elevated prevalence of TBI and chronic HBV infection. Cotesting for TBI and HBV infection in non\u2013US-born persons from countries with high TB and HBV burden might improve outcomes by identifying persons who warrant TBI treatment, HBV treatment, or HBV vaccination. Increased screening is the first step in reducing health inequities and overall disease burden.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae484","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T14:34:57Z","timestamp":1725374097000},"source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis and Chronic Hepatitis B Virus Infection Screening Among Non-US\u2013Born Persons in an Integrated Health System in California"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0550-2638","authenticated-orcid":false,"given":"Jenna M","family":"Wick","sequence":"first","affiliation":[{"name":"Internal Medicine Residency Program, Oakland Medical Center, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuching","family":"Ni","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Halmer","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-2806","authenticated-orcid":false,"given":"Robert J","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine , Stanford, California ,","place":["USA"]},{"name":"Gastroenterology and Hepatology Section, Veterans Affairs Palo Alto Healthcare System , Palo Alto, California \u00a0","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit S","family":"Chitnis","sequence":"additional","affiliation":[{"name":"Tuberculosis Section, Division of Communicable Disease Control and Prevention, Alameda County Public Health Department , San Leandro, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devan","family":"Jaganath","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L","family":"Krueger","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]},{"name":"Department of Infectious Diseases, Oakland Medical Center, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]},{"name":"Physician Researcher Program, Kaiser Permanente Northern California , Oakland, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"2024092714541533000_ofae484-B1","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011\u20132012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"2024092714541533000_ofae484-B2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3201\/eid2410.180716","article-title":"Simple estimates for local prevalence of latent tuberculosis infection, United States, 2011\u20132015","volume":"24","author":"Haddad","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024092714541533000_ofae484-B3","doi-asserted-by":"crossref","first-page":"e2312114","DOI":"10.1001\/jamanetworkopen.2023.12114","article-title":"Screening for latent tuberculosis infection","volume":"6","author":"Menzies","year":"2023","journal-title":"JAMA Netw Open"},{"volume-title":"Reported tuberculosis in the United States, 2022","year":"2023","author":"Centers for Disease Control and Prevention","key":"2024092714541533000_ofae484-B4"},{"key":"2024092714541533000_ofae484-B5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2024092714541533000_ofae484-B6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PHH.0000000000001536","article-title":"Prevalence of hepatitis B virus and latent tuberculosis coinfection in the United States","volume":"28","author":"Wong","year":"2022","journal-title":"J Public Health Manag Pract"},{"key":"2024092714541533000_ofae484-B7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jvh.13823","article-title":"Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States","volume":"30","author":"Wong","year":"2023","journal-title":"J Viral Hepat"},{"key":"2024092714541533000_ofae484-B8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciae169","article-title":"Epidemiology and treatment outcomes of tuberculosis with chronic hepatitis B infection\u2013California, 2016\u20132020","volume":"79","author":"Bertumen","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024092714541533000_ofae484-B9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"key":"2024092714541533000_ofae484-B10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"author":"World Health Organization Hepatitis Programme","key":"2024092714541533000_ofae484-B11"},{"key":"2024092714541533000_ofae484-B12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.1840080527","article-title":"A longitudinal follow-up of asymptomatic hepatitis B surface antigen\u2013positive Chinese children","volume":"8","author":"Lok","year":"1988","journal-title":"Hepatology"},{"key":"2024092714541533000_ofae484-B13","doi-asserted-by":"crossref","first-page":"e0118","DOI":"10.1097\/HC9.0000000000000118","article-title":"Prevalence and awareness of hepatitis B virus infection in the United States: January 2017\u2013March 2020","volume":"7","author":"Bixler","year":"2023","journal-title":"Hepatol Commun"},{"key":"2024092714541533000_ofae484-B14","doi-asserted-by":"crossref","first-page":"e201844","DOI":"10.1001\/jamanetworkopen.2020.1844","article-title":"Diagnosis rates of chronic hepatitis B in privately insured patients in the United States","volume":"3","author":"Ogawa","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024092714541533000_ofae484-B15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024092714541533000_ofae484-B16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the advisory committee on immunization practices\u2014United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024092714541533000_ofae484-B17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"author":"Centers for Disease Control","key":"2024092714541533000_ofae484-B18"},{"key":"2024092714541533000_ofae484-B19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024092714541533000_ofae484-B20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"author":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention","key":"2024092714541533000_ofae484-B21"},{"key":"2024092714541533000_ofae484-B22","doi-asserted-by":"crossref","first-page":"ofad303","DOI":"10.1093\/ofid\/ofad303","article-title":"Latent tuberculosis screening cascade for non\u2013US-born persons in a large health system","volume":"10","author":"Shapiro","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024092714541533000_ofae484-B23","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.focus.2023.100148","article-title":"Using electronic health record data to measure the latent tuberculosis infection care cascade in safety-net primary care clinics","volume":"2","author":"Vonnahme","year":"2023","journal-title":"AJPM Focus"},{"article-title":"Viral hepatitis national strategic plan: a roadmap to elimination for the United States (2021\u20132025)","year":"2020","author":"US Department of Health and Human Services","key":"2024092714541533000_ofae484-B24"},{"key":"2024092714541533000_ofae484-B25","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s10620-021-07056-5","article-title":"Prevalence of latent tuberculosis infection among persons with chronic hepatitis B virus infection: a systematic review and meta-analysis","volume":"67","author":"Chen","year":"2022","journal-title":"Dig Dis Sci"},{"key":"2024092714541533000_ofae484-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae484\/59002747\/ofae484.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae484\/59361502\/ofae484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae484\/59361502\/ofae484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:54:28Z","timestamp":1727448868000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae484\/7748281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae484","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,30]]},"article-number":"ofae484"}}